Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Acceptance of Human Papillomavirus Vaccination in Postpartum Women

Completed

Conditions: Human Papilloma Virus
HPV
Post Partum

First Posted Date: 2008-08-08

Last Posted Date: 2012-11-04

Lead Sponsor: Columbia University

Target Recruit Count: 150

Registration Number: NCT00730704

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Evaluating the Effectiveness of a Family Heart Health Educational Program (The FIT-Heart Study)

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Heart Diseases

Interventions: Behavioral: Family Passport to Heart Health Program
Behavioral: General Educational Materials

First Posted Date: 2008-08-06

Last Posted Date: 2013-05-15

Lead Sponsor: Columbia University

Target Recruit Count: 501

Registration Number: NCT00728637

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Adult Growth Hormone Deficiency and Cardiovascular Risk

Phase 4

Terminated

Conditions: Growth Hormone Deficiency

Interventions: Procedure: Blood draws
Drug: growth hormone releasing hormone (GHRH) & arginine
Procedure: Carotid ultrasound
Procedure: MRI
Procedure: Endothelial cell biopsy

First Posted Date: 2008-07-23

Last Posted Date: 2022-11-16

Lead Sponsor: Columbia University

Target Recruit Count: 7

Registration Number: NCT00720902

Locations: 🇺🇸
Columbia University, College of Physicians and Surgeons, New York, New York, United States

Effect of Oral Choline Supplementation on Postoperative Pain

Phase 4

Completed

Conditions: Postoperative Pain
Inflammation

Interventions: Drug: Placebo
Drug: Choline

First Posted Date: 2008-07-22

Last Posted Date: 2024-07-09

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT00720343

Locations: 🇺🇸
New York Presbyterian Hospital, New York, New York, United States

Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome

Completed

Conditions: Congenital Heart Disease

First Posted Date: 2008-07-11

Last Posted Date: 2017-07-18

Lead Sponsor: Columbia University

Target Recruit Count: 51

Registration Number: NCT00713635

Locations: 🇺🇸
Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York, New York, New York, United States

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Not Applicable

Completed

Conditions: Pharmacokinetics

Interventions: Drug: NuvaRing

First Posted Date: 2008-07-04

Last Posted Date: 2015-04-30

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT00710606

Locations: 🇺🇸
Division of Family Planning and Preventive Services, New York, New York, United States

Trial of Leptin Administration After Roux-en-Y Gastric Bypass

Phase 1

Completed

Conditions: Overweight

Interventions: Drug: Leptin
Other: Placebo

First Posted Date: 2008-07-04

Last Posted Date: 2015-11-16

Lead Sponsor: Columbia University

Target Recruit Count: 31

Registration Number: NCT00710814

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Feasibility of Delphi Screener for Cervical Cytology

Phase 2

Completed

Conditions: Cervical Neoplasia

Interventions: Device: Delphi Screener

First Posted Date: 2008-06-20

Last Posted Date: 2014-01-13

Lead Sponsor: Columbia University

Target Recruit Count: 198

Registration Number: NCT00702208

Locations: 🇺🇸
Columbia University Presbyterian Hospital, New York, New York, United States

Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate

Not Applicable

Terminated

Conditions: Heart Failure

Interventions: Device: Medtronic Pacemaker

First Posted Date: 2008-06-17

Last Posted Date: 2018-04-27

Lead Sponsor: Columbia University

Target Recruit Count: 3

Registration Number: NCT00698139

Locations: 🇺🇸
Columbia University, New York, New York, United States

Patent Foramen Ovale in Cryptogenic Stroke Study

Phase 4

Completed

Conditions: Ischemic Stroke
Patent Foramen Ovale

Interventions: Drug: Warfarin
Drug: Aspirin

First Posted Date: 2008-06-13

Last Posted Date: 2011-09-15

Lead Sponsor: Columbia University

Target Recruit Count: 630

Registration Number: NCT00697151

Locations: 🇺🇸
Columbia College of Physicians and Surgeons, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy